Takeda

2 Big Reasons Exelixis, Inc. Soared 22% in January
Motley Fool
Thu, 02/2/17 - 09:17 am
Exelixis
Cotellic
Roche
cabozantinib
Takeda
On a deal spree, Takeda grabs Japanese cabo rights in $145M pact with Exelixis
Endpoints
Tue, 01/31/17 - 09:59 am
Takeda
Japan
cabozantinib
Exelixis
Pharma joins Gates Foundation, international governments in $1B outbreak prep group
Fierce Pharma
Sun, 01/22/17 - 01:43 pm
Gates Foundation
GSK
Merck
JNJ
Pfizer
Sanofi
Takeda
R&D
epidemics
How Takeda won a $5.2B bidding war — against itself
Endpoints
Fri, 01/20/17 - 12:24 pm
Takeda
M&A
Ariad Pharmaceuticals
Japan's Takeda ready for fresh acquisitions after $5.2 bln Ariad deal
Yahoo/Reuters
Wed, 01/11/17 - 09:55 am
Takeda
Ariad Pharma
M&A
Takeda deal results in a huge windfall for former Ariad CEO Harvey Berger
Bizjournals.com
Tue, 01/10/17 - 09:12 am
Takeda
Ariad Pharmaceuticals
Harvey Berger
Takeda Pharmaceutical to buy Ariad in $5.2 billion cash deal
Yahoo/AP
Mon, 01/9/17 - 10:13 am
Takeda
Ariad Pharmaceuticals
M&A
Tiny startup hooks Takeda in celiac deal
BioPharma Dive
Sat, 01/7/17 - 12:12 pm
Takeda
celiac disease
PvP Biologics
Fake News? Valeant May Crash On Tuesday
Seeking Alpha
Mon, 01/2/17 - 04:21 pm
Valeant Pharmaceuticals
M&A
Takeda
Will Takeda Buy Salix?
Seeking Alpha
Mon, 12/19/16 - 10:56 am
Takeda
Salix
M&A
Standing Up To The Test Of Time: Two Cancer Drugs That Could Survive A Hobbled FDA
Forbes
Thu, 12/8/16 - 09:59 am
FDA
Seattle Genetics
Takeda
Adcetris
Hodgkin's lymphoma
AbbVie
JNJ
Ibruvica
mantle cell lymphoma
Valeant: The Salix Sale Debacle
Seeking Alpha
Mon, 12/5/16 - 10:42 pm
Valeant Pharmaceuticals
Salix
M&A
Takeda
Valeant: Don't WrIte Off Salix's Sale Potential
Seeking Alpha
Thu, 12/1/16 - 04:27 pm
Valeant Pharmaceuticals
hirings
Salix
Takeda
M&A
Valeant in talks to sell Salix stomach-drug unit in $10 billion deal
Reuters
Wed, 11/2/16 - 11:04 am
Valeant Pharmaceuticals
Salix
M&A
Takeda
A drug used to treat Crohn’s disease could suppress HIV, monkey study suggests
Stat
Fri, 10/14/16 - 11:42 am
Crohn’s disease
HIV
vedolizumab
Entyvio
Takeda
Takeda broadens oncology pipeline with Crescendo deal
BioPharma Dive
Tue, 10/11/16 - 09:22 pm
Takeda
Crescendo Biologics
Humabody
R&D
Amgen's multiple myeloma drug falls short in late stage study
Yahoo/Reuters
Tue, 09/27/16 - 10:18 am
Amgen
Multiple Myeloma
Kyprolis
clinical trials
Takeda
Velcade
Takeover Chatter Around Clovis May Be Overdone
TheStreet.com
Fri, 09/23/16 - 10:10 pm
Clovis Oncology
M&A
Eli Lilly
Merck
Takeda
So Takeda wants to do up to $20B in M&A? Welcome to the bidding war for US biotechs
Endpoints
Wed, 09/14/16 - 09:12 am
M&A
Takeda
biotech
Takeda will transfer 300 staffers to CRO in ongoing R&D overhaul
Endpoints
Tue, 09/13/16 - 12:56 pm
Takeda
reorganization
R&D
CROs

Pages